Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sendi

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
The Netherlands Journal of Medicine|September 24, 2008
Reactivation of dormant microorganisms following a trauma. Pneumonia, sternal abscess and calcaneus osteomyelitis due to Mycobacterium tuberculosisP Sendi, A Friedl, P Graber, et al.
Journal of Dental Research|July 25, 2006
A cost-effectiveness analysis of implant overdenturesN U Zitzmann, C P Marinello, P Sendi
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 10, 2020
Bone and joint infections of the handP Sendi, A Kaempfen, I Uçkay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 21, 2011
Clinical comparison between exogenous and haematogenous periprosthetic joint infections caused by Staphylococcus aureusP Sendi, F Banderet, P Graber, et al.
Praxis|January 15, 1999
[Critical evaluation of a cost-effectiveness analysis]P P Sendi, H C Bucher, J Steurer
Praxis|May 25, 2007
[Chronic lymphocytic leukemia and loss of strength in the right arm--not a typical combination]P Sendi, E Puric, A Schönenberger, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 19, 2000
Uncertainty in decision models analyzing cost-effectivenessB A Craig, M A Black, P P Sendi
Schweizerische Medizinische Wochenschrift|August 23, 2000
Applying some UK Prospective Diabetes Study results to Switzerland: the cost-effectiveness of intensive glycaemic control with metformin versus conventional control in overweight patients with type-2 diabetesA J Palmer, P P Sendi, G A Spinas
Pharmacoeconomics|September 11, 2001
Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infectionP Sendi, A J Palmer, A Gafni, et al.
Health Economics|May 15, 2007
An opportunity cost approach to sample size calculation in cost-effectiveness analysisA Gafni, S D Walter, S Birch, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
The Netherlands Journal of Medicine|September 24, 2008
Reactivation of dormant microorganisms following a trauma. Pneumonia, sternal abscess and calcaneus osteomyelitis due to Mycobacterium tuberculosisP Sendi, A Friedl, P Graber, et al.
Journal of Dental Research|July 25, 2006
A cost-effectiveness analysis of implant overdenturesN U Zitzmann, C P Marinello, P Sendi
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 10, 2020
Bone and joint infections of the handP Sendi, A Kaempfen, I Uçkay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 21, 2011
Clinical comparison between exogenous and haematogenous periprosthetic joint infections caused by Staphylococcus aureusP Sendi, F Banderet, P Graber, et al.
Praxis|January 15, 1999
[Critical evaluation of a cost-effectiveness analysis]P P Sendi, H C Bucher, J Steurer
Praxis|May 25, 2007
[Chronic lymphocytic leukemia and loss of strength in the right arm--not a typical combination]P Sendi, E Puric, A Schönenberger, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 19, 2000
Uncertainty in decision models analyzing cost-effectivenessB A Craig, M A Black, P P Sendi
Schweizerische Medizinische Wochenschrift|August 23, 2000
Applying some UK Prospective Diabetes Study results to Switzerland: the cost-effectiveness of intensive glycaemic control with metformin versus conventional control in overweight patients with type-2 diabetesA J Palmer, P P Sendi, G A Spinas
Pharmacoeconomics|September 11, 2001
Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infectionP Sendi, A J Palmer, A Gafni, et al.
Health Economics|May 15, 2007
An opportunity cost approach to sample size calculation in cost-effectiveness analysisA Gafni, S D Walter, S Birch, et al.
Pageof 6